Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GOVX.........................................................................................................p/m
GOVX to the bird flu rescue .. Bird Flu in Cats New Jersey
Two domestic cats in New Jersey have tested positive for the highly pathogenic avian influenza (H5N1) in Hunterdon County. One feral cat developed severe disease, including neurologic signs, and was euthanized. Another indoor-outdoor cat also tested positive, and tests on other cats on the property are pending.
Additional Details:
Symptoms in Cats: Clinical signs of bird flu in cats can include respiratory signs (discharge from the eyes and mouth, sneezing, coughing, difficulty breathing) and neurologic signs.
Transmission: Cats can contract the virus through exposure to infected birds or other animals, contaminated environments, or by consuming raw/undercooked meat or milk from infected sources.
Prevention: Pet owners are advised to avoid feeding cats raw milk or meat, avoid contact with sick or dead birds and wildlife, and thoroughly wash hands and change clothes after handling sick animals.
Human Risk: While the risk of H5N1 infection to the general population remains low, close contact with infected animals can pose a risk. No human cases have been reported in New Jersey.
Reporting: New Jersey residents should contact their veterinarian if they have concerns about their pets. Suspect feline cases should be reported to the New Jersey Department of Health at 609-826-4872 or zoonoticrn@doh.nj.gov.
Nice candle on the close...🥳
GOVX...$1.74...🥳...Revresal Candle setting up here...
georgie18
Member Level
Re: None
Monday, January 27, 2025 12:52:55 PM
Post#
672505
of 674217
GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html
Yup...same here ...🥳
Loaded $1.50s buyers finally trickling in having no debt offering fulfilled a few months ago and $500 million in BARDA funding this will fly once again to $10 when the big hedge fund is ready to push it again
GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html
Bottom in low $2s as W pattern established ready for breakout soon. Could mean news
$2.74?Cancer vaccine patent awarded and remember 500 million from other studies being awarded by government low floater
GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
Anyone know if they working on H5N1?
GOVX $3.57 + 80% kept a few $1.70s.
GOVX $2.80s + 50%🔥🔥🔥🔥📞🚀🚀🚀🚀
Rockets fired $2.70s + 40% sold most
GOVX $1:96 + 1% earnings 11-12
Have plenty of $1.70s financial results Nov 12 afterhours
Some climbing again 2.26
crawling out of its hole
keep on watch
GOVX 2.20s offshore hedgies hit some.. The government will also provide around $343M for a clinical research organization to conduct the clinical trial. Under the agreement, BARDA will award GeoVax up to $45M for the manufacturing of clinical materials and support for the Phase 2b study
$2.07 Offshore hedgies could hit here again but could be a month or two out still
Ok ok we see you ..but going to hold $3s this time or another fake out. Support been at $2.60s past few weeks. Looking better
Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts
The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention
Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency
The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development
Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)
Looking good bottom about in for hedgies
Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t
Hedgies determine new downtrend. New entry as we see $2.80s for another flip
Ok hedgies confirming new upward trend perhaps give it a few hours still
Flip the $3.06 at 3.30s and wait for hedgies to determine direction
Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler
Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies
3.19 zone being tested if holds a few days start adding some again
price of $5.125 per share for expected gross proceeds of $5 million.
4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.
The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.
Net proceeds will be used for working capital and general corporate purposes, the company said.
The offering is expected to close around Friday, sub
Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please
Covid flue season blooming still holding a few here but inclined to add some more ..
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.
The Fauch knows how to party!
Maybe the evil bastard will drop dead .
Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection
Good, keep giving that evil idiot all my vaccines and boosters.
He should double up
Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times
Followers
|
265
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
19594
|
Created
|
12/11/01
|
Type
|
Free
|
Moderators |
July 26 (Reuters) - The Biden administration estimates it may need nearly $7 billion to deal with the monkeypox outbreak in the United States, the Washington Post reported on Tuesday.
The funding estimate was part of a memo marked to President Joe Biden outlining a series of options, as opposed to a formal funding request, the report said. (https://wapo.st/3oxXimZ)
The White House and the U.S. Department of Health and Human Services did not immediately respond to requests for comment.
CREDIT MONEYMADE FOR DD AND ALERTING GROUP BEFORE THE CLOSE. WEEEEEEEE $1.70https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169502961
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |